SD BIOSENSOR
SD BIOSENSOR. Introducing SD Biosensor, a healthy company that protects human health and is a global leader in diagnostic reagents that supplies platforms from screening tests to confirmation tests.
ABOUT US - SD BIOSENSOR
SD BIOSENSOR will develop and provide the diagnostic reagent to quickly and accurately diagnose various illnesses and new viruses threatening humanity. By contributing to medical treatment in this way, we will try our best in protecting the health of humanity.
At-Home OTC COVID-19 Diagnostic Tests - FDA
As the manufacturer, SD Biosensor, transitions to this new brand, customers may receive a product with the previously authorized COVID-19 At-Home Test labeling.
Do Not Use Certain SD Biosensor Pilot COVID-19 At-Home Tests
May 25, 2023 · The SD Biosensor Pilot COVID-19 At-Home Test is a lateral flow immunoassay device intended for the qualitative detection of the nucleocapsid protein antigen found in the SARS-CoV-2 virus.
Since 2010, SD BIOSENSOR has grown and evolved to make the world healthier through our innovative IVD products. Our goal is to be the global leading In-vitro diagnostics company.
About the COVID-19 At-Home Test 2 - Roche Diagnostics USA
Established in 2010, SD Biosensor has successfully launched diagnostics of blood glucose, glycated hemoglobin, and cholesterols globally, and with innovative products, are striving to become a leading global in vitro diagnostic company.
SD Biosensor, Inc.: Pilot COVID-19 At-Home Test 9-month to 12-month shelf-life extension granted by the FDA on October 14, 2022 Lot Number Tests with this printed expiration date...
WHO and MPP announce technology transfer license to enable …
Jan 31, 2024 · WHO and the Medicines Patent Pool (MPP) announce a license agreement with SD Biosensor Inc., a global in-vitro diagnostic company, to provide sublicensees with the right, know-how and material to manufacture SDB’s rapid diagnostic testing (RDT) technology.
Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for …
Mar 16, 2021 · Rapid detection of infection is essential for stopping the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Roche SD Biosensor rapid antigen test for SARS-CoV-2 was evaluated in a nonhospitalized symptomatic population.
Global partnership to make available 120 million affordable, …
Sep 28, 2020 · The tests developed by Abbott and SD Biosensor are highly portable, reliable, and easy to administer, making testing possible in near-person, decentralized healthcare settings.